Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 7NSCLC 2Advanced Non-Small Cell Lung Cancer 2Stomach Neoplasms 1Radiation Injuries 1Pancoast Syndrome 1Non-small Cell Lung Cancer Stage â…¡ 1Lung Neoplasms 1Carcinoma, Transitional Cell 1Advanced NSCLC With EGFR Mutation 1

Interventions

S 1 (combination) 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced NSCLC With EGFR Mutation × S 1 (combination) × Thoracic × Clear all
NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Henan Cancer Hospital

Phase 2 Unknown
200 enrolled
Thoracic

Advanced NSCLC With EGFR Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡